CH532600A - Process for the preparation of novel imidazo (4,5-b) pyridine derivatives - Google Patents

Process for the preparation of novel imidazo (4,5-b) pyridine derivatives

Info

Publication number
CH532600A
CH532600A CH1372371A CH1372371A CH532600A CH 532600 A CH532600 A CH 532600A CH 1372371 A CH1372371 A CH 1372371A CH 1372371 A CH1372371 A CH 1372371A CH 532600 A CH532600 A CH 532600A
Authority
CH
Switzerland
Prior art keywords
preparation
pyridine derivatives
novel imidazo
imidazo
novel
Prior art date
Application number
CH1372371A
Other languages
French (fr)
Inventor
Boesch Roger
Original Assignee
Rhone Poulenc Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7034133A external-priority patent/FR2105060A1/en
Priority claimed from FR7130825A external-priority patent/FR2150236A2/en
Application filed by Rhone Poulenc Sa filed Critical Rhone Poulenc Sa
Priority to CH1614872A priority Critical patent/CH532602A/en
Priority to CH1614772A priority patent/CH532601A/en
Publication of CH532600A publication Critical patent/CH532600A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CH1372371A 1970-09-21 1971-09-20 Process for the preparation of novel imidazo (4,5-b) pyridine derivatives CH532600A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CH1614872A CH532602A (en) 1970-09-21 1971-09-20 Anthelmintic imidazo (4,5-b) pyridine derivs
CH1614772A CH532601A (en) 1971-08-25 1971-09-20 Anthelmintic imidazo (4,5-b) pyridine derivs

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7034133A FR2105060A1 (en) 1970-09-21 1970-09-21 Anthelmintic imidazo (4,5-b) pyridine derivs - with low mammalian toxicity,for oral human and veterinary use
FR7130825A FR2150236A2 (en) 1971-08-25 1971-08-25 Anthelmintic imidazo (4,5-b) pyridine derivs - with low mammalian toxicity,for oral human and veterinary use

Publications (1)

Publication Number Publication Date
CH532600A true CH532600A (en) 1973-01-15

Family

ID=26215952

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1372371A CH532600A (en) 1970-09-21 1971-09-20 Process for the preparation of novel imidazo (4,5-b) pyridine derivatives

Country Status (13)

Country Link
AU (1) AU453067B2 (en)
BE (1) BE772835A (en)
CA (1) CA940131A (en)
CH (1) CH532600A (en)
DE (1) DE2147103C3 (en)
DK (1) DK131345B (en)
ES (2) ES395260A1 (en)
GB (1) GB1318859A (en)
HU (1) HU163150B (en)
IL (1) IL37752A (en)
LU (1) LU63927A1 (en)
NL (1) NL145553B (en)
SE (1) SE368828B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60021065T2 (en) 1999-03-31 2006-06-01 UAF Technologies and Research, LLC, Tucson VIRUS TREATMENT
US6593466B1 (en) 1999-07-07 2003-07-15 Isis Pharmaceuticals, Inc. Guanidinium functionalized nucleotides and precursors thereof
US6384049B1 (en) * 2000-05-25 2002-05-07 The Procter & Gamble Company Cancer treatment

Also Published As

Publication number Publication date
DE2147103B2 (en) 1974-11-14
SE368828B (en) 1974-07-22
BE772835A (en) 1972-03-20
DE2147103C3 (en) 1975-07-17
CA940131A (en) 1974-01-15
NL145553B (en) 1975-04-15
LU63927A1 (en) 1972-06-27
IL37752A0 (en) 1971-11-29
GB1318859A (en) 1973-05-31
DE2147103A1 (en) 1972-03-23
IL37752A (en) 1974-10-22
NL7112971A (en) 1972-03-23
ES395260A1 (en) 1973-12-01
AU3373571A (en) 1973-03-29
HU163150B (en) 1973-06-28
DK131345B (en) 1975-06-30
AU453067B2 (en) 1974-09-19
DK131345C (en) 1975-11-24
ES403910A1 (en) 1975-05-01

Similar Documents

Publication Publication Date Title
CH522595A (en) Process for the preparation of new tricyclic derivatives
OA03907A (en) Process for the preparation of new derivatives of isoindoline.
CH513193A (en) Process for the preparation of novel derivatives of 5-hydroxy-methyl-2-oxazolidinone
OA04406A (en) Process for the preparation of 14-hydroxy-morphinan derivatives.
CH532575A (en) Process for the preparation of new isoindoline derivatives
CH507958A (en) Process for the preparation of novel imidazole derivatives
OA04825A (en) Process for the preparation of novel 2-phenoxyacetamido-5-nitro-thiazole derivatives.
CH509975A (en) Process for the preparation of phloramine derivatives
CH513192A (en) Process for the preparation of new derivatives of aminocarbonyl-3-oxazolidinone-2
CH522632A (en) Process for the preparation of novel derivatives of amino-methyl-4'-spiro (dibenzo (a-d) cycloheptadi- (or tri-) ene-5: 2'-dioxolane (1 ', 3'))
CH540912A (en) Process for the preparation of novel phenanthridine derivatives
CH531002A (en) Process for the preparation of new cephalosporin derivatives
OA03891A (en) Process for the preparation of dihydrotriazine derivatives.
CH532600A (en) Process for the preparation of novel imidazo (4,5-b) pyridine derivatives
CH507265A (en) Process for the preparation of new nitrogenous derivatives of 2-methyl-3-benzylimidazo-3 H (4,5-b) pyridine
CH525864A (en) Process for the preparation of new tricyclic derivatives
OA04117A (en) Process for the preparation of new derivatives of Burgo (b) tiophéine.
OA03905A (en) Process for the preparation of novel thiazolino-pyrimidone-5 derivatives.
CH498127A (en) Process for the preparation of novel 3,5-dihydrophenazine derivatives
CH535248A (en) Process for the preparation of new hydroco-cobalamin derivatives
CH511883A (en) Process for the preparation of derivatives of 2,3,4,4a-tetrahydro-10H-1,2-oxazino (3,2-b) - (1,3) benzoxazin-10-one
CH535228A (en) Process for the preparation of novel derivatives of trimethyl-1,7,7 norbornane-2-spiro-2'-dioxolane-1 ', 3'
CH522675A (en) Process for the preparation of novel derivatives of (piperidine-4 spiro) 5 oxazolidinones-2
OA03435A (en) Process for the preparation of benzodiazepine derivatives.
OA03484A (en) Process for the preparation of pyrrole derivatives.

Legal Events

Date Code Title Description
PL Patent ceased